Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 13 - Number 5




Proteasome as an Emerging Therapeutic Target in Cancer

, 13(5): 471 - 485

I. Zavrski, L. Kleeberg, M. Kaiser, C. Fleissner, U. Heider, J. Sterz, C. Jakob and O. Sezer


DOI: 10.2174/138161207780162908




Current Concepts for the Combined Treatment Modality of Ionizing Radiation with Anticancer Agents

, 13(5): 519 - 535

Christoph Oehler, Daniel J. Dickinson, Angela Broggini-Tenzer, Barbara Hofstetter, Andreas Hollenstein, Oliver Riesterer, Van Vuong and Martin Pruschy


DOI: 10.2174/138161207780162935




Editor-in-Chief

Alessandro Antonelli
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)

Biography
View Full Editorial Board

Executive Editor

Atta-ur-Rahman, FRS
(29381 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography

View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks.
Scopus CiteScore Metrics: 2.32

Advertisement

October Health DaysPLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog